Cover Image

Differential Immunoexpression of BRAF/V600E, Senescence Markers, PTEN, and T-type Calcium Channels in Acquired Naevi According to their Histopathological and Dermoscopic Classification

BRAF/V600E mutation and other cell growth/growth-control mechanisms are involved in naevogenesis and melanomagenesis. Immunoexpression of BRAF/V600E and other molecules (p16, phosphatase and tensin homologue (PTEN), Ki67, hTERT and Cav3.1 and 3.2 calcium channels) were investigated in 80 histopatho...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sara Moreno (Author), Oscar Maiques (Author), Carla Barcelo (Author), Marta Romero (Author), Maria Santacana (Author), Ignacio Gómez (Author), Dolors Cuevas (Author), Ana Velasco (Author), Alvar Vea (Author), Anna Macia (Author), Ramon Boix (Author), Joan Valls (Author), Sonia Gatius (Author), Carles Canti (Author), Xavier Matias-Guiu (Author), Xavier Soria (Author), Rosa M. Marti (Author)
Format:	Book
Published:	Medical Journals Sweden, 2021-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias
by: Cristina Mirantes, et al.
Published: (2013)

BRAFV600E and KIT immunoexpression in early-stage melanoma
by: Andressa Germano, et al.

Amelanotic primary dermal melanoma with V600E BRAF mutation
by: Miho Kabuto, et al.
Published: (2017)

BRAF V600 Mutation Profile of Metastatic Melanoma in the Thrace Region of Turkey
by: Nuray CAN, et al.
Published: (2018)

High BRAF V600 Mutation Level Associated with Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors
by: Ariane Fizazi, et al.
Published: (2024)

Impact of posaconazole and diltiazem on pharmacokinetics of encorafenib, a BRAF V600 kinase inhibitor for melanoma and colorectal cancer with BRAF mutations
by: Erik Hahn, et al.
Published: (2023)

Visual Impact of Large and Giant Congenital Naevi: Comparison of Surgical Scars with Naevi Before Surgery
by: Francesca Sampogna, et al.
Published: (2021)

Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1
by: Meijia Yang, et al.
Published: (2017)

Targeted therapy- Vemurafinib in BRAF V600E positive Langerhan cell histiocytosis
by: Mohammed Naseer, et al.
Published: (2017)

Targeted Therapy- Vemurafinib in BRAF V600E positive langerhan cell histiocytosis
by: Mohammed Naseer, et al.
Published: (2017)

Prevalence and Main Determinants of BRAF V600E Mutation in Dysplastic and Congenital Nevi
by: Maryam Nasimi, et al.
Published: (2021)

Adult Langerhans cell histiocytosis with a rare BRAF V600E and V600D mutation, diagnosed through oral manifestations
by: Soukaïna Oujdad, et al.
Published: (2022)

BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate
by: Sara V. Bates, et al.
Published: (2013)

Clinico-economic analysis of PD-1 inhibitors and combinations of BRAF and MEK inhibitors for the treatment of metastatic melanoma with a BRAF V600 gene mutation
by: D. Yu. Belousov, et al.
Published: (2018)

Inmunoexpresión de CAV-1, PTEN, EGFR, KRAS, BRAF V600E, CRAF, MEK y MAPK/ERK en Mixomas odontogénicos y gérmenes dentarios asociados a su comportamiento biológico
by: Gabriela Vigil, et al.
Published: (2023)

Inmunoexpresión de CAV-1, PTEN, EGFR, KRAS, BRAF V600E, CRAF, MEK Y MAPK/ERK en mixomas odontogénicos y gérmenes dentarios asociados a su comportamiento biológico
by: GABRIELA VIGIL, et al.
Published: (2022)

Inmunoexpresión de CAV-1, PTEN, EGFR, KRAS, BRAF V600E, CRAF, MEK y MAPK/ERK en Mixomas odontogénicos y gérmenes dentarios asociados a su comportamiento biológico
by: Gabriela Vigil, et al.
Published: (2023)

Inmunoexpresión de CAV-1, PTEN, EGFR, KRAS, BRAF V600E, CRAF, MEK Y MAPK/ERK en mixomas odontogénicos y gérmenes dentarios asociados a su comportamiento biológico
by: GABRIELA VIGIL, et al.
Published: (2022)

Early molecular diagnosis of BRAF status drives the neurosurgical management in BRAF V600E-mutant pediatric low-grade gliomas: a case report
by: Gianluca Piccolo, et al.
Published: (2022)

Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis
by: Lucrezia Togni, et al.
Published: (2022)

Three cases of congenital self‐healing Langerhans cell histiocytosis with BRAF‐V600E mutation
by: Mar Ramírez‐Lluch, et al.
Published: (2022)

Adult‐onset BRAF V600E‐related multisystem Langerhans cell histiocytosis treated with vemurafenib
by: Lisa Denise A. Encarnacion‐Mangubat, et al.
Published: (2024)

Targeting Non-V600 Mutations in BRAF: A Single Institution Retrospective Analysis and Review of the Literature
by: Hirra A. Chaudhary, et al.
Published: (2024)

Pharmacoeconomic analysis of vemurafenib and dabrafenib use in patients with inoperable or metastatic melanoma with BRAF V600 mutation
by: A. S. Kolbin, et al.
Published: (2018)

Immunoexpression of PTEN, HER2/neu, and Ki-67 in endoscopic gastric carcinoma biopsies; their correlation with histological subtypes and one-year survival
by: Seema Acharya, et al.
Published: (2022)

Giant Congenital Melanocytic Naevi: review of literature
by: A. Marchesi, et al.
Published: (2012)

Impressive clinical response following combined BRAF and MEK inhibition in a low-grade serous ovarian carcinoma patient with a BRAF V600E mutation
by: Anna Rodzajewska, et al.
Published: (2023)

To Correlate the Expression of KRAS and BRAF V600e with Histological Grades and Variants in Tissue Samples of Colorectal Carcinoma
by: Hina Wasti, et al.
Published: (2023)

A study of pathological characteristics and BRAF V600E status in Langerhans cell histiocytosis of Vietnamese children
by: Thu Dang Anh Phan, et al.
Published: (2021)

The association of BRAF V600E gene mutation with proliferative activity and histopathological characteristics of congenital melanocytic nevi in children
by: Jianyou Chen, et al.
Published: (2023)

Utility of BRAF VE1 Immunohistochemistry as a Screening Tool for Colorectal Cancer Harboring V600E Mutation
by: Jeong-Hwa Kwon, et al.
Published: (2018)

Multisystemic Pediatric Langerhans cell histiocytosis: a comprehensive clinico-pathological and BRAF V600E mutation study at autopsy
by: Gargi Kapatia, et al.
Published: (2021)

Treating malignant melanoma when a rare BRAF V600M mutation is present: case report and literature review
by: Popescu Andrei, et al.
Published: (2018)

Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China
by: Meiling Huang, et al.
Published: (2019)

Immunohistochemical Investigation of Mutant BRAF V600E in Common Pigmented Skin Neoplasms, Study on a Sample of Iranian Patients
by: Maryam Ghasemi, et al.
Published: (1999)

Turner Syndrome, Atypical Naevi and Multiple Melanoma: Coincidence or Causality?
by: Julia M.K. Clabbers, et al.
Published: (2023)

Differential Clinicopathological Features in Spontaneous Regression of Melanomas and Melanocytic Naevi
by: José M. Martín, et al.
Published: (2017)

Caracterização da População com Mutação BRAF V600 nos Doentes com Melanoma Cutâneo Metastizado num Centro Terciário
by: Maria Mendonça-Sanches, et al.
Published: (2020)

DNA Mismatch Repair Proteins and BRAF V600E Detection by Immunohistochemistry in Colorectal Cancer Demonstrates Concordance with Next Generation Sequencing
by: Joel Yambert, et al.
Published: (2022)

Increased diagnostic sensitivity of palpation‐guided thyroid nodule fine‐needle aspiration cytology by BRAF V600E‐mutation analysis
by: Oliver Gimm, et al.
Published: (2021)